Carl Rickenbaugh

President, First Keel Consulting; current board member Paragonix Technologies; former M&A Head Bard Peripheral Vascular & Biopsy (13 years); and M&A Head at EQT Private Equity Company Clinical Innovations (successfully exited to Patricia AB company Laborie Medical in 2020); leadership in sales, marketing and product development at Abbott Laboratories (13 years).